The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,275.00
Bid: 2,265.00
Ask: 2,275.00
Change: 10.00 (0.44%)
Spread: 10.00 (0.442%)
Open: 2,320.00
High: 2,320.00
Low: 2,255.00
Prev. Close: 2,265.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Mar 2018 09:28

RNS Number : 9602G
Morgan Sindall Group PLC
07 March 2018
 

Morgan Sindall Group plc (the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

The following notification is intended to satisfy the Company's obligations under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

1.

Details of Restricted Person/person closely associated with them ("PCA")

a)

Name

John Morgan (Chief Executive)

Steve Crummett (Finance Director)

2.

Reason for the notification  

a)

Position/status

Members of the Board of directors

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Morgan Sindall Group plc

b)

LEI

2138008339ULDGZRB345

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence each

 

ISIN: GB0008085614 

b)

Nature of the transaction

Grant of conditional awards over Ordinary Shares on 6 March 2018, under the Company's 2014 Long Term Incentive Plan, adopted by the Company on 30 July 2014 ("2014 LTIP"). Each conditional award will vest on 6 March 2021 subject to the satisfaction of performance criteria. Each conditional award carries a right to receive, on vesting, an amount linked to dividends paid on the Ordinary Shares subject to the conditional award. The dividend equivalent can be settled in cash or Ordinary shares of the Company.

c)

Price(s) and volume(s)

Name

Price(s)

Volume(s)

John Morgan

N/A

61,666

Steve Crummett

N/A

49,171

d)

Aggregated information

- Aggregated volume

- Price

As above

 

e)

Date of the transaction

6 March 2018

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLIFFAVDIDIIT
Date   Source Headline
1st May 202010:54 amRNSTotal Voting Rights
1st May 202010:37 amRNSChange in Director's details
27th Apr 202010:40 amRNSDisclosure of rights attached to equity shares
20th Apr 20201:10 pmRNSBlock listing Interim Review
2nd Apr 20202:57 pmRNSAnnual Financial Report
1st Apr 202012:08 pmRNSTotal Voting Rights
25th Mar 20207:00 amRNSCOVID-19 Update
11th Mar 20203:45 pmRNSHolding(s) in Company
11th Mar 20208:30 amRNSAdditional Listing
9th Mar 20202:33 pmRNSHolding(s) in Company
9th Mar 20202:13 pmRNSDirector/PDMR Shareholding
3rd Mar 20202:14 pmRNSHolding(s) in Company
2nd Mar 20204:15 pmRNSDirector/PDMR Shareholding
2nd Mar 20204:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:19 pmRNSTotal Voting Rights
27th Feb 20202:02 pmRNSHolding(s) in Company
27th Feb 20201:48 pmRNSHolding(s) in Company
27th Feb 20201:39 pmRNSHolding(s) in Company
27th Feb 202010:35 amRNSDirector/PDMR Shareholding
24th Feb 20205:45 pmRNSSophos Group
20th Feb 20207:00 amRNSFinal Results
3rd Feb 20204:20 pmRNSTotal Voting Rights
31st Jan 20203:44 pmRNSHolding(s) in Company
29th Jan 20204:18 pmRNSHolding(s) in Company
24th Jan 20203:25 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSDirectorate Change
9th Jan 20207:00 amRNSNotice of Results
7th Jan 20204:39 pmRNSHolding(s) in Company
2nd Jan 20208:30 amRNSTotal Voting Rights
21st Nov 20199:21 amRNSDirector/PDMR Shareholding
20th Nov 201911:43 amRNSAdditional Listing
18th Nov 20199:48 amRNSAppointment to c£650m Slough scheme
18th Nov 20197:00 amRNSSenior Management Forum
11th Nov 201912:05 pmRNSHolding(s) in Company
11th Nov 201910:25 amRNSDirector/PDMR Shareholding
6th Nov 20197:00 amRNSTrading Update
1st Nov 20191:58 pmRNSTotal Voting Rights
21st Oct 201910:07 amRNSBlock listing Interim Review
8th Oct 20194:37 pmRNSPrice Monitoring Extension
2nd Oct 20194:08 pmRNSHolding(s) in Company
1st Oct 201910:19 amRNSTotal Voting Rights
3rd Sep 201911:30 amRNSAdditional Listing
2nd Sep 20192:49 pmRNSTotal Voting Rights
13th Aug 20193:34 pmRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 201910:08 amRNSTotal Voting Rights
30th Jul 20194:44 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSNotice of Results
1st Jul 201910:20 amRNSTotal Voting Rights
24th Jun 20194:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.